Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1949 1
1950 6
1951 4
1952 1
1953 1
1954 2
1955 2
1956 2
1957 2
1958 2
1959 3
1961 3
1962 3
1963 5
1964 2
1965 1
1966 2
1967 3
1968 5
1971 1
1975 1
1980 1
1988 1
1989 1
1990 1
1991 1
1994 1
1995 1
1996 1
1997 2
1998 5
1999 5
2000 3
2002 1
2003 2
2005 1
2006 4
2007 3
2008 4
2009 5
2010 4
2011 2
2012 8
2013 6
2014 3
2015 7
2016 7
2017 6
2018 5
2019 4
2020 15
2021 8
2022 6
2023 5
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

178 results

Results by year

Filters applied: . Clear all
Page 1
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups. Hauser SL, et al. N Engl J Med. 2020 Aug 6;383(6):546-557. doi: 10.1056/NEJMoa1917246. N Engl J Med. 2020. PMID: 32757523 Clinical Trial.
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
Loss of the Atrial Fibrillation-Related Gene, Zfhx3, Results in Atrial Dilation and Arrhythmias.
Jameson HS, Hanley A, Hill MC, Xiao L, Ye J, Bapat A, Ronzier E, Hall AW, Hucker WJ, Clauss S, Barazza M, Silber E, Mina JA, Tucker NR, Mills RW, Dong JT, Milan DJ, Ellinor PT. Jameson HS, et al. Among authors: silber e. Circ Res. 2023 Aug 4;133(4):313-329. doi: 10.1161/CIRCRESAHA.123.323029. Epub 2023 Jul 14. Circ Res. 2023. PMID: 37449401 Free article.
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P; FREEDOMS Study Group. Kappos L, et al. N Engl J Med. 2010 Feb 4;362(5):387-401. doi: 10.1056/NEJMoa0909494. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089952 Free article. Clinical Trial.
Osteoporosis in multiple sclerosis.
Hearn AP, Silber E. Hearn AP, et al. Among authors: silber e. Mult Scler. 2010 Sep;16(9):1031-43. doi: 10.1177/1352458510368985. Epub 2010 Jun 15. Mult Scler. 2010. PMID: 20551086 Review.
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial.
Brittain G, Petrie J, Duffy KEM, Glover R, Hullock K, Papaioannou D, Roldan E, Beecher C, Bursnall M, Ciccarelli O, Coles AJ, Cooper C, Giovannoni G, Gabriel I, Kazmi M, Kyriakou C, Nicholas R, Paling D, Peniket A, Scolding N, Silber E, de Silva T, Venneri A, Walters SJ, Young C, Muraro PA, Sharrack B, Snowden JA; StarMS trial team. Brittain G, et al. Among authors: silber e. BMJ Open. 2024 Feb 5;14(2):e083582. doi: 10.1136/bmjopen-2023-083582. BMJ Open. 2024. PMID: 38316583 Free PMC article.
Diabetes and neurology: hemichorea-hemiballism in hyperglycaemia.
Galloway KY, Younus O, Quattrocchi G, Raheem B, Dervenoulas G, Silber E. Galloway KY, et al. Among authors: silber e. Clin Med (Lond). 2020 Mar;20(Suppl 2):s21-s22. doi: 10.7861/clinmed.20-2-s21. Clin Med (Lond). 2020. PMID: 32409348 Free PMC article. No abstract available.
Real-world incidence of fingolimod-associated macular oedema.
Goh LY, Kirthi V, Silber E, Harvey JP, Jackson TL. Goh LY, et al. Among authors: silber e. Mult Scler Relat Disord. 2020 Jul;42:102125. doi: 10.1016/j.msard.2020.102125. Epub 2020 Apr 28. Mult Scler Relat Disord. 2020. PMID: 32403070
178 results